This book delves into the transformative power of AI in the realm of neurodegenerative diseases,covering topics such as ALS, Huntington’s, Parkinson’s, and Alzheimer’s. Generative AIprovides new opportunities for early diagnosis, precise therapy, and individualized rehabilitation,which are crucial as these conditions remain major obstacles for healthcare providersand researchers. Researchers, physicians, AI developers, and healthcare professionals will find this bookan invaluable resource for understanding how AI is influencing the development of treatmentsfor neurodegenerative diseases. It describes important obstacles and future directions whileproviding insights into the newest breakthroughs, thus bridging the gap between technologyand practical clinical applications. Anyone involved in neurodegenerative healthcare, fromscientists conducting AI-driven medical research to physicians seeking to incorporate AI intopatient care or AI professionals investigating new healthcare applications, will find the informationand insights they need in this comprehensive book. Predictive analytics, biomarker identification, and drug discovery are being transformedby AI-driven models, such as deep neural networks, generative adversarial networks (GANs),and variational autoencoders (VAEs). This book offers a comprehensive examination of thesedevelopments. Robots, wearable sensors, and cognitive therapy platforms are some of theAI-enhanced rehabilitation tools covered, as are AI-integrated cutting-edge technologies likefMRI and MRI, gene-editing methods like CRISPR, and more. In addition to discussing recent technical developments, this book takes a close look atthe data privacy, ethics, and regulatory issues that arise when using AI to study neurodegenerativedisorders. Issues like algorithmic bias, model explainability, and fair AI-driven healthcareare thoroughly investigated in light of the growing usage of AI models in clinical decision-making,mental health applications, and cognitive rehabilitation.